Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Changsha,Hunan,China

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Payment Terms: L/L

    Huateng Pharmaceutical, a global supplier of pharmaceutical intermediates, offers Remdesivir intermediates Pyrrolo[2,1-f][1,2,4]triazin-4-amine (CAS NO. 159326-68-8) for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation

    Remdesivir, also known as GS-5734, is a novel antiviral drug in the class of nucleotide analogs developed by Gilead Sciences. In February 2020 Remdesivir was being studied for experimental treatment of the emergent COVID-19 (novel coronavirus) disease.

Send your message to this supplier
  • From:
  • To:
    Hunan HuaTeng Pharmaceutical Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service